A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer

Cancer Epidemiology

Volumn 36, Issue 5, 2012, Pages

  Jsorgensen, Timothy J ^a   Ruczinski, Ingo ^b   Yao Shugart, Yin ^c   Wheless, Lee ^d   Berthier Schaad, Yvette ^b,e   Kessing, Bailey ^e   Hoffman Bolton, Judith ^b,f   Helzlsouer, Kathy J ^g   Kao, W H Linda ^b   Francis, Lesley ^d   Alani, Rhoda M ^h   Strickland, Paul T ^b   Smith, Michael W ^e   Alberg, Anthony J ^d  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e SAIC FREDERICK INC   (United States)

^f George W Comstock Center for Public Health Research and Prevention   (United States)

^g MERCY MEDICAL CENTER   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fas; Genetics; Hedgehog; Polymorphisms; Skin cancer; Vitamin D receptor

Indexed keywords

PROTEIN PATCHED 2; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; SUPPRESSOR OF FUSED PROTEIN; TRANSCRIPTION FACTOR GLI1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; NEOPLASM; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; ANTIGENS, CD95; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEDGEHOG PROTEINS; HUMANS; MALE; MARYLAND; MEDICAL RECORD LINKAGE; MIDDLE AGED; MUTATION; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RISK FACTORS; SKIN NEOPLASMS; SMOKING;

EID: 84865863540     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.05.001     Document Type: Article

References (23)

1. Rogers H.W., Weinstock M.A., Harris A.R., Hinckley M.R., Feldman S.R., Fleischer A.B., et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010, 146(3):283-287.
2. Chen J., Ruczinski I., Jorgensen T.J., Yenokyan G., Yao Y., Alani R., et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008, 100(17):1215-1222.
3. Wheless L., Black J., Alberg A.J. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2010, 19(7):1686-1695.
4. Bale A.E., Yu K.P. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 2001, 10(7):757-762.
5. Caro I., Low J.A. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment. Clin Cancer Res 2010, 16(13):3335-3339.
6. Lupi O. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma. Int J Dermatol 2007, 46(11):1113-1117.
7. Gorlin R.J. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004, 6(6):530-539.
8. Evangelista M., Tian H., de Sauvage F.J. The hedgehog signaling pathway in cancer. Clin Cancer Res 2006, 12(20 (Pt 1)):5924-5928.
9. Yang L., Xie G., Fan Q., Xie J. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010, 29(4):469-481.
10. Li C., Chi S., He N., Zhang X., Guicherit O., Wagner R., et al. IFN-alpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling. Oncogene 2004, 23(8):1608-1617.
11. Teichert A.E., Elalieh H., Elias P.M., Welsh J., Bikle D.D. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice. J Invest Dermatol 2011, 131(11):2289-2297.
12. Gallicchio L., Chang H.H., Christo D.K., Thuita L., Huang H.Y., Strickland P., et al. Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study. BMC Med Genet 2009, 10:103.
13. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005, 37(11):1217-1223.
14. Wigginton J.E., Cutler D.J., Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76(5):887-893.
15. Asplund A., Gustafsson A.C., Wikonkal N.M., Sela A., Leffell D.J., Kidd K., et al. PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer. Br J Dermatol 2005, 152(5):868-873.
16. Liboutet M., Portela M., Delestaing G., Vilmer C., Dupin N., Gorin I., et al. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J Invest Dermatol 2006, 126(7):1510-1517.
17. Strange R.C., El-Genidy N., Ramachandran S., Lovatt T.J., Fryer A.A., Smith A.G., et al. Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms. Ann Hum Genet 2004, 68(Pt 6):536-545.
18. Chang-Claude J., Dunning A., Schnitzbauer U., Galmbacher P., Tee L., Wjst M., et al. The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk. Int J Cancer 2003, 103(6):779-783.
19. Abuli A., Fernandez-Rozadilla C., Giraldez M.D., Munoz J., Gonzalo V., Bessa X., et al. A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22. Br J Cancer 2011, 105(6):870-875.
20. Watson A., Kent P., Alam M., Paller A.S., Umbach D.M., Yoon J.W., et al. GLI1 genotypes do not predict basal cell carcinoma risk: a case control study. Mol Cancer 2009, 8:113.
21. Chen M., Hildebrandt M.A., Clague J., Kamat A.M., Picornell A., Chang J., et al. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res 2010, 3(10):1235-1245.
22. Denzer N., Vogt T., Reichrath J. Vitamin D receptor (VDR) polymorphisms and skin cancer: a systematic review. Dermatoendocrinology 2011, 3(3):205-210.
23. Kostner K., Denzer N., Koreng M., Reichrath S., Graber S., Klein R., et al. Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): A pilot study in a German population. Anticancer Res 2012, 32(1):327-333.